Skip to main content
SpringerLink
Log in

125I Embolotheraphy of Renal Tumors

  • Chapter
Renal and Adrenal Tumors

  • 121 Accesses

Abstract

Radical nephrectomy is the procedure of choice for management of (Robson) stage 1 and 2 renal cell carcinomas (Table 1) [1–3]. Expanded surgical procedures have made possible the attack and successful removal of tumor extensions into the inferior vena cava and even into the right atrium and ventricle [4–8]. The 5-year survival rate for stage 1 and 2 renal cell carcinomas managed by radical nephrectomy has been reported as 67% and 51% respectively [3]. Even in patients with tumor extension into the inferior vena cava, the infrahepatic segment of the inferior vena cava, or the right atrium, 30–40 percentile 5-year survival rates are reported for surgical procedures extirpating the primary lesion and intravascular tumor extension [6–8].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Robson CJ, Churchill BM, Anderson W (1969) The results of radical nephrectomy for renal cell carcinoma. J Urol 101: 297–301

    PubMed  CAS  Google Scholar 

  2. Freed SZ, Feldman JA, Srayragen S (1977) Follow up of patients after nephrectomy for renal cell carcinoma. Urology 9: 500–503

    Article  PubMed  CAS  Google Scholar 

  3. McNichols DW, Segura JW, DeWeerd JH (1981) Renal cell carcinoma: long term survival and late recurrence. J Urol 126: 17–23

    PubMed  CAS  Google Scholar 

  4. Kearney GP, Waters WB, Klein LA, Richie JP, Gittes RF (1981) Results of inferior vena cava resection for renal cell carcinoma. J Urol 125: 769–773

    PubMed  CAS  Google Scholar 

  5. Cummings JB, Li W, Ryan JA, Horton WG, Paton RR (1979) Operative management of renal cell carcinoma with supradiaphragmatic caval extension. J Urol 122: 829–832

    PubMed  CAS  Google Scholar 

  6. Waters WB, Richie JP (1979) Aggressive surgical approach to renal cell carcinoma: review of 130 cases. J Urol 122: 306–309

    PubMed  CAS  Google Scholar 

  7. Novick AC, Cosgrove DM (1980) Surgical approach for removal of renal cell carcinoma extending into the vena cava and the right atrium. J Urol 123: 947–950

    PubMed  CAS  Google Scholar 

  8. Skinner DG, Pfister RF, Colvin R (1972) Extension of renal cell carcinoma into the vena cava: the rationale for aggressive surgical management. J Urol 107: 711–716

    PubMed  CAS  Google Scholar 

  9. Giuliani L, Martorana G, Giberti C, Pescatore D, Magnani G (1983) Results of radical nephrectomy with extensive lymphadenectomy for renal cell carcinoma. J Urol 130: 664–668

    PubMed  CAS  Google Scholar 

  10. Peters PC, Brown GL (1980) The role of lymphadenectomy in the management of renal cell carcinoma. Urol Clin North Am 7: 705–709

    PubMed  CAS  Google Scholar 

  11. O’Dea MJ, Zincke H, Utz DC, Bernatz PE (1978) The treatment of renal cell carcinoma with solitary metastasis. J Urol 120: 540–542

    PubMed  Google Scholar 

  12. Fuselier HA, Guice SL, Brannan W, Ochsner MG, Sangisetty KV, Beckman EN, Barnes CA (1983) Renal cell carcinoma. The Ochsner Medical Institution experience (1945–1978). J Urol 130: 445–448

    PubMed  Google Scholar 

  13. DeKernion JB, Ramming KP, Smith RB (1978) The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol 120: 148–152

    PubMed  CAS  Google Scholar 

  14. Middleton RG (1967) Surgery for metastatic renal cell carcinoma. J Urol 97: 973–977

    PubMed  CAS  Google Scholar 

  15. Barney JD, Churchill EJ (1939) Adenocarcinoma of the kidney with metastasis to the lung: cured by nephrectomy and lobectomy. J Urol 42: 269–276

    Google Scholar 

  16. Hrushesky WJ, Murphy JP (1977) Current status of therapy of advanced renal carcinoma. J Surg Oncol 9: 277–288

    Article  PubMed  CAS  Google Scholar 

  17. DeKernion JB (1983) Treatment of advanced renal cell carcinoma-Traditional methods and innovative approaches. J Urol 130: 2–7

    PubMed  CAS  Google Scholar 

  18. Nemoto R, Kato T, Iwata K, et al. (1930) Evaluation of therapeutic arterial embolization in renal cell carcinoma using microencapsulated mytomycin-c. Urology 17: 315–319

    Article  Google Scholar 

  19. Neidhart JA, Murphy SG, Hennick LA, Wise AJ (1980) Active specific immunotherapy of stage IV renal cell carcinoma with aggregated tumor antigen adjuvant. Cancer 46: 1128–1134

    Article  PubMed  CAS  Google Scholar 

  20. Montie JE, Bukowski RM, James RE, Straffm RA, Stewart BH (1982) A critical review of immunotherapy of disseminated renal adenocarcinoma. J Surg Oncol 21: 5–8

    Article  PubMed  CAS  Google Scholar 

  21. DeKernion JB, Sarna G, Figlin R, Lindner A, Smith RB (1983) The treatment of renal cell carcinoma with human leukocyte alpha-interferon. J Urol 130: 1063–1066

    PubMed  CAS  Google Scholar 

  22. Quesada JR, Swanson DA, Trindade A, Gutterman JU (1983) Renal cell carcinoma antitumor effective leukocyte interferon. Cancer Res 43: 940–947

    PubMed  CAS  Google Scholar 

  23. DeKernion JB, Ramming KP (1980) The therapy of renal adenocarcinoma with immune RNA. Invest Urol 17: 378–381

    PubMed  CAS  Google Scholar 

  24. Morales A, Kiruluta G, Lott S (1975) Hormones in treatment of metastatic renal cancer. J Urol 114: 692–693

    PubMed  CAS  Google Scholar 

  25. Pierson J, Friedman MA, Hoffman DJ Jr (1981) Hormone receptor in renal cell carcinoma: their utility as predictors of response to endocrine therapy. Cancer Chemother Pharmacol 6: 151

    Google Scholar 

  26. Nakno E, Tada Y, Fujioka H, Matsuda M, Osafune M, Kotake T, Sato B, Takaha M, Sonoda T (1984) Hormone receptor in renal cell carcinoma and correlation with clinical response to endocrine therapy. J Urol 132: 240–245

    Google Scholar 

  27. Satomi Y, Takai S, Kondo I, Fukshima S, Furuhata A (1982) Postoperative prophylactic use of progesterone in renal cell carcinoma. J Urol 128: 919–922

    PubMed  CAS  Google Scholar 

  28. Arkell DJ, Cotter KP, Fitz-Patrick JD, Shaw RE (1978) Preoperative arterial embolisation of renal carcinoma. Br J Urol 50: 469–473

    Article  PubMed  CAS  Google Scholar 

  29. Wallace S, Chuang VP, Swanson D, Bracken B, Hersh EM, Ayala A, Johnson D (1981) Embolization of renal carcinoma: experience with 100 patients. Radiology 138: 563–570

    PubMed  CAS  Google Scholar 

  30. Weigel JW, Mebost WK, Forat JD, Nobel MJ, Voptka T, Krishnan EC, Jewell WR (1985) Treatment of renal cell carcinoma with renal infarction delayed nephrectomy, medroxyprogesterone and xenogeneic immune RNA. Urology 25: 103–105

    Article  PubMed  CAS  Google Scholar 

  31. Swanson DE, Johnson DE, Von Eschenbach AC, Chuang VP, Wallace S (1983) Angioinfarction plus nephrectomy for metastatic renal cell carcinoma - an update. J Urol 130: 449–452

    PubMed  CAS  Google Scholar 

  32. Gottesman JE, Crawford ED, Grossman HB, Scardino P, McCrecken JD (1985) Infarction - nephrectomy of metastatic renal cell carcinoma. Urology 25: 248–250

    Article  PubMed  CAS  Google Scholar 

  33. Lang EK (1970) Superselective arterial catheterization of tumors of the urogenital tract: a modality used for perfusion with chemotherapeutic agents and infarction with radioactive pellets. J Urol 104: 16–25

    PubMed  CAS  Google Scholar 

  34. Lang EK (1971) Superselective arterial catheterization as a vehicle for delivering radioactive infarct particles to tumors. Radiology 98: 391–399

    PubMed  CAS  Google Scholar 

  35. Lang EK (1975) Local regional treatment of neoplasm by radioactive infarct particles introduced by arterial catheterization. Panminerva Med 17: 398–404

    PubMed  CAS  Google Scholar 

  36. Lang EK, DeKernion JB (1981) Transcatheter embolization of advanced renal cell carcinoma with radioactive seeds. J Urol 126: 581–586

    PubMed  CAS  Google Scholar 

  37. Lang EK, Sullivan F, DeKernion JB (1983) Work in progress: transcatheter embolization of renal cell carcinoma with radioactive infarct particles. Radiology 147: 413–418

    PubMed  CAS  Google Scholar 

  38. Lang EK (1982) Advanced renal cell carcinoma treatment by transcatheter embolization with inert material and radioactive particles. In: Ariel JM (ed) Prog Clin Cancer 8: 299–310. Grune + Stratton, NY

    Google Scholar 

  39. Lang EK (1984) Transcatheter embolization of renal cell carcinoma. In: Lang EK (ed) Current concepts of uroradiology, Chapter 12. Williams and Wilkins, Baltimore

    Google Scholar 

  40. Prager MD, Baechtel FS, Peters PC, Brown GL, Greene CL (1981) Specific immunotherapy of human metastatic renal cell carcinoma. In: Proceedings American association of cancer research. Am Assoc Clin Oncol 22: 163 (abstract 647)

    Google Scholar 

Download references

Authors
  1. E. K. Lang
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Röntgendiagnostisches Zentralinstitut, Klinikum der Universität Essen, Hufelandstraße 55, D-4300, Essen, Germany

    Eberhard Löhr

  2. Institut für Pathologie, Klinikum der Universität Essen, Hufelandstraße 55, D-4300, Essen, Germany

    Lutz-Dietrich Leder

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lang, E.K. (1987). 125I Embolotheraphy of Renal Tumors. In: Löhr, E., Leder, LD. (eds) Renal and Adrenal Tumors. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71207-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71207-4_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-71209-8

  • Online ISBN: 978-3-642-71207-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation